CBT-I vs MBCT
A side-by-side comparison of recorded mechanisms, evidence review status, related condition topics, and philosophical roots.
At a glance
Source checks, condition-specific assessments and expert review are separate steps. Each assessment applies only to its stated population and use. Topic links do not establish comparative effectiveness.
CBT-I
- Tradition
- Cognitive-Behavioral
- Founder
- Bootzin / Spielman / Morin / Perlis (1987)
- Review status
- 3 condition assessments available
- Official sources
Guidelines and official sources (5)
5 clinical guideline checks
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- Behavioral and psychological treatments for chronic insomnia disorder in adults
Recommendation for the stated population
AASM strongly recommends multicomponent CBT-I. Its 2021 review did not directly compare psychotherapy with medication.
Scope: Adults with chronic insomnia disorder, with or without comorbidities
- Combination treatment for chronic insomnia disorder in adults
Recommendation for the stated population
AASM conditionally favors CBT-I plus medication over medication alone, and CBT-I alone over the combination; both use low-certainty evidence and allow preference-based exceptions.
Scope: Adults with chronic insomnia; concurrent initiation of medication and CBT-I
- Management of chronic insomnia disorder in adults
Recommendation for the stated population
ACP recommends CBT-I initially; after an unsuccessful course, it suggests shared decisions about adding short-term medication.
Scope: Adults with chronic insomnia disorder
- Daridorexant for treating long-term insomnia (TA922)
Discussed in the source
NICE describes CBT-I as the standard first treatment; daridorexant eligibility requires CBT-I to have failed, be unavailable or be unsuitable. This is a drug technology appraisal, so identify that context.
Scope: Adults with long-term insomnia being considered for daridorexant
- Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea
Recommendation for the stated population
VA/DoD strongly recommends CBT-I and weakly favors CBT-I over medication initially. These recommendations address insomnia, not treatment of its comorbid diagnoses.
Scope: Adults with chronic insomnia disorder; initial treatment selection.
- Behavioral and psychological treatments for chronic insomnia disorder in adults
- Focus
- Skill-building
- Format
- Individual or group
- Duration
- Short-term (4–8 sessions)
Condition-specific assessments
Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.
Insomnia & Sleep Disorders
Population and scope: Adults with chronic insomnia disorder receiving multicomponent CBT-I. This assessment concerns insomnia, including when it co-occurs with another condition; it does not grade treatment of obstructive sleep apnea, circadian disorders or the co-occurring diagnosis itself.
Guideline recommendation
AASM’s 2021 recommendation 1 and VA/DoD’s 2025 recommendation 5 strongly recommend multicomponent CBT-I for adult chronic insomnia. VA/DoD recommendation 8 only weakly favors CBT-I over medication as initial treatment. AASM’s 2026 combination guideline conditionally favors CBT-I alone over starting CBT-I and medication together, with low-certainty evidence and preference-based exceptions. The guideline label therefore applies to the defined insomnia treatment, not sleep hygiene alone, every digital program, every sleep disorder or universal superiority to medication.
Source assessment dated
- American Academy of Sleep Medicine (2021-02-01; JCSM 17(2):255–262; DOI 10.5664/jcsm.8986): Behavioral and psychological treatments for chronic insomnia disorder in adults — Methods and Table 1, printed p. 256 / physical PDF p. 2; Recommendation 1 and Remarks, printed p. 257 / physical PDF p. 3
- US Department of Veterans Affairs / Department of Defense (Version 3.0; January 2025; evidence through 2024-03-31; current PDF filename dated 2025-09-15): Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea — Table 4, recommendations 5 and 8, printed/PDF p. 34
- American Academy of Sleep Medicine (2026-04-13; JCSM 22:56; evidence through June 2025): Combination treatment for chronic insomnia disorder in adults — Recommendations 1 and 2 and remark to Recommendation 2, physical PDF p. 1; Methods/Introduction, physical PDF pp. 1–2; current AASM Practice Guidelines directory
Anxiety Disorders
Population and scope: Adults with co-occurring clinically elevated insomnia and anxiety symptoms, selected using ISI and GAD-7 thresholds, receiving a supported four-lesson internet CBT-I program.
Randomized studies
Mason et al. (2023) randomized 120 adults to internet CBT-I or internet CBT for anxiety. Both groups reported reduced anxiety; GAD-7 improvement did not differ significantly between groups through three-month follow-up. CBT-I improved insomnia more at post-treatment, but that sleep advantage did not persist significantly at follow-up. The active-comparator study does not establish equivalence, anxiety-diagnosis remission, or effects in anxiety without insomnia. Entry used symptom thresholds, and diagnostic interviews were not repeated after treatment. This scoped randomized-study label does not borrow the separate insomnia guideline recommendation.
Source assessment dated
Depression & Mood Disorders
Population and scope: Adults aged 18–75 with both major depressive disorder and insomnia, receiving antidepressant pharmacotherapy in the 150-person TRIAD trial.
Randomized studies
Manber et al. (2016) compared seven-session CBT-I with a credible insomnia control therapy, both added to antidepressant treatment, over 16 weeks. The primary time-to-depression-remission outcome did not differ significantly; neither did depression symptom improvement. Insomnia improved more with CBT-I. Secondary analyses linked early sleep improvement with subsequent depression remission, but do not overturn the null primary comparison. Recruitment was below target. This evaluates an adjunct for comorbid insomnia and depression, not standalone depression treatment or depression without insomnia.
Source assessment dated
MBCT
- Tradition
- Cognitive-Behavioral
- Founder
- Segal / Williams / Teasdale (2002)
- Review status
- 1 condition assessment available
- Official sources
Guidelines and official sources (14)
13 clinical guideline checks · 1 evidence registry check
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- Depression in adults: treatment and management (NG222)
Recommendation for the stated population
NICE lists group MBCT as a relapse-prevention option, with or without continuing antidepressants according to preference.
Scope: People remitted on antidepressants alone and at higher relapse risk
- Mindfulness-based cognitive therapy
Discussed in the source
The archive lists Strong under 1998 criteria and pending 2015 re-evaluation.
Scope: MBCT; depression/relapse prevention evidence
- Depression in adults: treatment and management (NG222)
Recommendation for the stated population
NICE includes group mindfulness and meditation using a programme such as MBCT among treatment options. This is separate from its relapse-prevention recommendations.
Scope: Adults with a new episode of less severe depression; depression-specific group programme.
- Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder
Insufficient evidence for or against
VA/DoD finds insufficient evidence for or against MBCT for PTSD.
Scope: Adults with PTSD; mind-body interventions.
- Management of Major Depressive Disorder
Recommendation for the stated population
VA/DoD suggests mindfulness-based cognitive therapy among seven unranked psychotherapy options (weak for). Treatment strategy also depends on severity, chronicity, prior response and preference.
Scope: Adults with uncomplicated MDD choosing psychotherapy.
- Management of Major Depressive Disorder
Discussed in the source
VA/DoD strongly recommends first-line evidence-based psychotherapy, referring to the list that includes mindfulness-based cognitive therapy. This is a class-level recommendation, with no preferred individual approach.
Scope: Pregnant or breastfeeding adults with mild-to-moderate MDD.
- Management of Major Depressive Disorder
Recommendation for the stated population
VA/DoD suggests MBCT during continuation treatment to reduce relapse or recurrence (weak for). CBT, IPT and MBCT are not ranked against one another.
Scope: Remitted MDD with high risk of relapse or recurrence.
- Clinical Practice Guideline for the Management of Chronic Multisymptom Illness
Discussed in the source
The guideline discusses an IBS adaptation of MBCT within a weak recommendation for mindfulness-based therapies. This is not a separate recommendation for standard MBCT across all chronic multisymptom illnesses.
Scope: MBCT adapted for IBS within the chronic multisymptom illness guideline.
- Management of Headache
Discussed in the source
The recommendation is neutral for the mindfulness-based therapy category; the discussion includes MBCT. It does not assign MBCT a separate recommendation grade.
Scope: Mindfulness-based interventions for headache treatment or prevention.
- Tinnitus
Discussed in the source
The guideline is neutral for mindfulness-based therapies. MBCT appears in the evidence discussion, without a separate MBCT recommendation grade.
Scope: Mindfulness-based therapies for adults with bothersome tinnitus.
- Management of Type 2 Diabetes Mellitus
Discussed in the source
The review includes MBCT within mindfulness/acceptance interventions. The graded recommendation concerns a stress-reduction programme category, without a separate MBCT grade or established long-term benefit.
Scope: Adults with stress related to type 2 diabetes.
- Clinical Practice Guideline for Management of Stroke Rehabilitation
Discussed in the source
VA/DoD weakly recommends mindfulness-based therapies and specifically reviews MBSR and MBCT. The recommendation is for the therapy family in this post-stroke population.
Scope: Depression following stroke.
- Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts
Discussed in the source
APA includes MBCT among broadly comparable models; it cannot recommend a superior monotherapy.
Scope: Adults with depressive disorders, excluding psychotic depression; initial monotherapy selection.
- Clinical Practice Guideline for Tobacco Use Treatment
Discussed in the source
VA/DoD weakly recommends against standalone mindfulness for this cessation goal. This is category-level guidance; MBCT is not separately graded, and the statement does not address adjunctive use or other conditions.
Scope: Mindfulness used as a standalone treatment for abstinence from tobacco or nicotine.
- Depression in adults: treatment and management (NG222)
- Focus
- Skill + Experiential
- Format
- Group
- Duration
- Short (8-week)
Condition-specific assessments
Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.
Depression & Mood Disorders
Population and scope: Adults with uncomplicated MDD, or remitted MDD with high relapse risk.
Guideline recommendation
VA/DoD 2022 weakly includes MBCT for initial psychotherapy selection (recommendation 7) and separately for continuation after remission in patients at high relapse risk (22). Neither recommendation establishes superiority; acute treatment and relapse prevention are distinct scopes.
Source assessment dated
How they work
CBT-I
Core mechanism: Sleep restriction and stimulus control consolidate sleep drive and decondition wakefulness; cognitive restructuring reduces hyperarousal and catastrophic thinking about sleep
Ontology: Chronic insomnia as a learned disorder of hyperarousal and conditioned sleeplessness maintained by maladaptive behaviors and beliefs, not a primary neurological deficit
MBCT
Core mechanism: Mindful awareness of depressive cognitive patterns enables decentering and prevents ruminative relapse spirals
Ontology: Depressive relapse maintained by reactivation of ruminative cognitive patterns triggered by low mood
Related condition topics
These editorial cross-references organize reading. A shared link does not mean both approaches are effective, recommended, or interchangeable for that condition.
2 shared · 4 CBT-I-only · 0 MBCT-only
Linked to both entries
Linked only in the CBT-I entry
What each assumes — and misses
CBT-I
Philosophical roots: Behavioral learning theory (Pavlov, Skinner); cognitive appraisal theory; Spielman's 3P model (predisposing, precipitating, perpetuating factors)
Blind spots: Sleep restriction can be challenging for people with bipolar disorder (may trigger mania); requires motivation and tolerance of short-term worsening; group or digital formats may not address comorbidities
Therapeutic voice: We're going to compress the time you spend in bed to build up your sleep drive. It will feel harder before it feels easier.
MBCT
Philosophical roots: Buddhist psychology (mindfulness, non-attachment to thoughts); Husserl (epoché: suspending natural attitude); Kabat-Zinn (secularized dharma); Teasdale (interacting cognitive subsystems)
Blind spots: Primarily relapse prevention: not first-line for acute depression; requires meditation capacity some clients lack
Therapeutic voice: Notice the thought arriving, not as truth, but as a mental event. Thoughts are not facts.
Choosing between them
CBT-I and MBCT both sit within the Cognitive-Behavioral tradition — they share a worldview about what suffering is and how change happens. Differences are more often about technique and emphasis than about underlying theory.
For deeper coverage: see the full CBT-I and MBCT pages, or use the interactive comparison tool to add more modalities to this comparison.